ProfoundBio: Funding, Investors & Team (Oct 2026)
ProfoundBio is a clinical-stage biotechnology company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer. Built on internally developed, innovative, and proprietary technology platforms, ProfoundBio has developed a pipeline consisting of multiple antibody-drug conjugate (ADC) drug candidates targeting solid tumors and hematological malignancies that are in discovery, preclinical, and clinical development stages.
ProfoundBio has raised $112M across 1 funding round on record, the most recent a Series B of $112M announced in Feb 2024.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
ProfoundBio Company Profile and Key Stats
Latest funding round on record: Feb 2024.
ProfoundBio Funding Rounds
ProfoundBio Founders and Leadership Team
Contact details for the ProfoundBio team: 1 of 1 has an email address on file.
Start 14-day free trial →ProfoundBio Funding Compared to Other Biotechnology Startups
ProfoundBio's latest round of $112M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like ProfoundBio in Biotechnology and Seattle
Companies Similar to ProfoundBio
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
ProfoundBio Funding FAQs
What does ProfoundBio do?
ProfoundBio is a clinical-stage biotechnology company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer. Built on internally developed, innovative, and proprietary technology platforms, ProfoundBio has developed a pipeline consisting of multiple antibody-drug conjugate (ADC) drug candidates targeting solid tumors and hematological malignancies that are in discovery, preclinical, and clinical development stages.
How much funding has ProfoundBio raised?
ProfoundBio has raised $112M across 1 round on record. The most recent is a Series B of $112M announced in Feb 2024.
When did ProfoundBio last raise funding?
ProfoundBio's most recent funding round on record is a Series B of $112M, announced in Feb 2024.
Who founded ProfoundBio?
FundedIQ lists Tae Han (Founder) at ProfoundBio.
Where is ProfoundBio headquartered?
ProfoundBio is based in Seattle, Washington, United States.
How many employees does ProfoundBio have?
ProfoundBio is in the 51-100 employee band.
How does ProfoundBio's funding compare to other Biotechnology startups?
ProfoundBio's latest round of $112M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's ProfoundBio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ProfoundBio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.